Supplementary Materials
Gut microbiota linked to sexual preference and HIV infection Marc Noguera-Julian
1,2,3†
1,3 1,3 1,2 1,3 , Muntsa Rocafort †, Yolanda Guillén , Javier Rivera , Maria Casadellà ,
4
5
5
1
1
1
Piotr Nowak , Falk Hildebrand , Georg Zeller , Mariona Parera , Rocío Bellido , Cristina Rodríguez , Jorge Carrillo 8
1,3,7
, Beatriz Mothe
1,2,3,6
1,6
6
6
6
, Josep Coll , Isabel Bravo , Carla Estany , Cristina Herrero , Jorge
6
9
9
9
Saz , Guillem Sirera , Ariadna Torrela , Jordi Navarro , Manel Crespo , Christian Brander Negredo
2,3,6
, Julià Blanco
1,2,3
11
2
, Francisco Guarner , Maria Luz Calle , Peer Bork
4
Sönnerborg , Bonaventura Clotet
1,2,3,6
, Roger Paredes*
5,12,13
1,2,3,10
, Eugènia
, Anders
1,2,3,6
1
irsiCaixa AIDS Research Institute, Ctra de Canyet s/n, 08916 Badalona, Catalonia, Spain. Universitat de Vic-Universitat Central de Catalunya, C. Sagrada Família 7, 08500 Vic, Catalonia, Spain. 3 Universitat Autònoma de Barcelona, 08193 Bellaterra, Catalonia, Spain. 4 Department of Medicine, Unit of Infectious Diseases, Karolinska University Hospital, Karolinska Institutet, Huddinge 141, 86 Stockholm, Sweden. 5 Structural and Computational Biology, European Molecular Biology Laboratory, Meyerhofstrasse 1, 69117 Heidelberg, Germany. 6 HIV Unit & Lluita contra la SIDA Foundation, Hospital Universitari Germans Trias i Pujol, Ctra de Canyet s/n, 08916 Badalona, Catalonia, Spain. 7 ISGLOBAL, Carrer Rosselló, 132, 08036 Barcelona, Catalonia, Spain. 8 BCN Checkpoint, Carrer del Comte Borrell, 164, 08015 Barcelona, Catalonia, Spain. 9 Infectious Diseases Unit, Hospital Universitari Vall d’Hebrón, Passeig de la Vall d'Hebrón, 119-129, 08035 Barcelona, Catalonia, Spain. 10 Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Catalonia, Spain. 11 Digestive Diseases Department, Vall d’Hebrón Institute of Research, Hospital Universitari Vall d’Hebrón, Passeig de la Vall d'Hebrón, 119-129, 08035 Barcelona, Catalonia, Spain. 12 Max-Delbrück-Centre for Molecular Medicine, Robert-Rössle-Str. 10, 13092 Berlin, Germany. 13 Molecular Medicine Partnership Unit, EMBL, Meyerhofstrasse 1, 69117 Heidelberg, Germany. 2
†!Contributed
equally to this work
* Corresponding author: Dr. Roger Paredes, HIV Unit and irsiCaixa AIDS Research Institute, Ctra de Canyet s/n, 08916 Badalona, Catalonia, Spain. Tel: + 34 93 465 6374 (Ext: 162) email:
[email protected]
!
1
Supplementary Methods HIV phenotype definitions To ensure that the study included a representative spectrum of different HIV-1 phenotypes, HIV-infected subjects had to belong to one of the following groups: (a) elite controllers, defined as subjects with HIV-1 RNA 10,000 copies/mL, nadir CD4+ T-cell counts>500 cells/mm and no ART exposure; (d) late 3
presenters, with CD4+ T-cell counts < 200 cells/mm at diagnosis and no ART exposure; (e) immune 3
discordant, maintaining HIV-1 RNA